A. Schematic of the EGFR protein. Red lines indicate the peptide epitopes selected as part of our vaccine.
B. Representation of the homology between the peptides composing the vaccine and corresponding mouse sequences.
C. Schematic of the experimental design outlining timing of vaccine administration, induction of the oncogenic transgene, imaging time points and experimental endpoint.